GlobeNewswire PharmaOriginal article
5-årsuppföljning stödjer säkerhet och indikerar positiv behandlingseffekt av Renaparin®
Data ReadoutpositiveRenaparinPositive
AI Analysis
Summary
Corline Biomedical reported 5-year follow-up data from the RENAPAIR 01 study demonstrating safety and positive therapeutic effect of Renaparin, with comparison to transplanted kidneys.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
5-year follow-up demonstrates safety and indicates positive therapeutic effect
Importance:5/10
Sentiment:
0.70
long-term safety datatreatment efficacyRENAPAIR 01 trialkidney transplantation
Read the original article
Published by GlobeNewswire Pharma on July 2, 2026 2:32 PM